More women opt for genetic screening to detect infant disability risk
Despite an increase in the number of women taking the test, the abortion rate has remained stable
Keystone
More than one in four expecting Swiss mothers undergo non-invasive prenatal genetic screening to identify chromosomal abnormalities like Down syndrome in their potential offspring.
According to the latest figures from the Federal Office of Public Health, 25,000 out of 87,000 expecting mothers undergo non-invasive prenatal genetic screening every year, report the Le Matin Dimanche and Sonntags Zeitung papers. The test, which costs CHF800 ($834.4), detects trisomy 21 (Down syndrome), 18 and 13 with a 99% reliability. The risk of having a child with such a disability is significant once the probability exceeds 0.1% (chance of one in a thousand). Around 80% of the women who opt for a genetic screening do so between the 11th and 14th week of pregnancy.
Despite the availability of the genetic screening test for the last five years, the number of abortions have remained stable. In 2016, 70 children were born with Down syndrome, which represents 0.8% of all newborns, as many as in previous years.
How is your country dealing with the return of stolen artifacts?
Western nations like Switzerland often have to deal with the process of recovering or returning looted artifacts which have been illegally imported. What’s the situation like in your country?
What do you think Switzerland’s Alain Berset can bring to the Council of Europe?
The former interior minister is to become the first Swiss Secretary General of the Council of Europe – which issues should his five-year term focus on?
Swiss Solidarity raises over CHF10 million for victims of extreme weather
This content was published on
The money raised will be used to help those affected by the recent storms and flooding in the cantons of Ticino, Graubünden, and Valais.
Swiss giant Roche given green light for lung cancer drug in Canada
This content was published on
According to a recent study, Roche’s Alecensaro reduced the risk of recurrence or death by 76% compared to chemotherapy alone.
Swiss luxury watch market hit hard by China-led slump
This content was published on
Sales of Swiss-made luxury watches are in sharp retreat as nervous consumers reconsider splashing out on expensive timepieces and demand slumps.
Swiss foreign minister briefs Russian counterpart on Ukraine peace summit
This content was published on
Swiss Foreign Minister Ignazio Cassis met with his Russian counterpart Sergei Lavrov in New York, during Russia's presidency of the UN Security Council.
Criminal proceedings filed over Swiss components in Russian weapons
This content was published on
The Swiss State Secretariat for Economic Affairs has opened more than 50 administrative criminal proceedings for violations of sanctions against Russia.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss back genetic testing of embryos (again)
This content was published on
Switzerland is set to become the last country in Europe to allow in vitro embryos to be tested for genetic disorders before they are implanted in a woman’s uterus.
More IVF babies born in Switzerland than ever before
This content was published on
A record number of Swiss couples have had a child by successfully using IVF, according to the latest figures published by the Swiss Federal Statistical Office (FSO) on Tuesday. The FSO says 2,162 babies conceived with the help of IVF were born in 2016, compared with 2,020 in 2015 (up 7%). It also notes a…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.